Werewolf Therapeutics Inc.
HOWL | NASDAQ
$0.98
+$0.02 (+1.55%)
At close: Sep 21, 2026, 4:00 PM ET
$0.98
$0 (+0.33%)
Pre-market:
Sep 22, 2026, 7:57 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 1.89M | 19.94M | 16.4M | n/a | n/a |
Cost of Revenue | 1.63M | 1.81M | 1.76M | 2.51M | n/a | 777K |
Gross Profit | -1.63M | 71K | 18.18M | 13.89M | n/a | -777K |
Operating Income | -60.68M | -73.59M | -40.5M | -56.06M | -50.09M | -22.4M |
Interest Income | 3.11M | 6.67M | 7.42M | 1.91M | 104K | 101K |
Pretax Income | -60.82M | -70.52M | -37.37M | -53.81M | -49.98M | -15.04M |
Net Income | -60.82M | -70.52M | -37.37M | -53.81M | -49.98M | -14.94M |
Selling & General & Admin | 15.85M | 19.05M | 18.67M | 21.5M | 14.82M | 5.76M |
Research & Development | 44.83M | 56.43M | 41.78M | 53.76M | 35.27M | 16.64M |
Other Expenses | -1.63M | -1.81M | -1.76M | -5.32M | n/a | -777K |
Operating Expenses | 59.04M | 73.67M | 58.68M | 69.95M | 50.09M | 21.63M |
Interest Expense | 5.27M | 4.66M | 3.14M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 4.17M | n/a | n/a |
Cost & Expenses | 60.68M | 75.48M | 60.45M | 72.46M | 50.09M | 22.4M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 46.02M | 43.33M | 35.65M | 28.86M | 18.46M | 28.66M |
Shares Outstanding (Diluted) | 46.81M | 43.86M | 35.65M | 28.86M | 18.46M | 28.66M |
EPS (Basic) | -1.32 | -1.63 | -1.05 | -1.86 | -10.94 | -0.98 |
EPS (Diluted) | -1.33 | -1.63 | -1.05 | -1.86 | -10.94 | -0.98 |
EBITDA | -53.91M | -64.05M | -32.47M | -51.3M | -49.77M | -14.26M |
EBIT | -55.55M | -65.86M | -34.23M | -53.81M | -49.98M | -15.04M |
Depreciation & Amortization | 1.63M | 1.81M | 1.76M | 2.51M | 216K | 777K |
Add to Watchlist
Select watchlists to add or remove HOWL